UCSD and J&J Draw Blueprint for Broad-Based Collaborative Research in Health Sciences | GenomeWeb
Johnson & Johnson and the University of California, San Diego, last month signed a broad-based memorandum of understanding that lays the groundwork for multiple research and educational collaborations in the health sciences, UCSD said recently.
 
The MOU, which involves several health sciences-related entities within UCSD, is the first agreement of its kind struck between UCSD and a pharmaceutical company, according to UCSD Vice Chancellor for Health Sciences David Brenner.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.